Skip to content
XSQ Life Sciences
Regulatory affairs

A regulatory roadmap that turns approval into a plan, not a gamble

Regulatory requirements shift across regions and product types, and a misread can cost months. We bring the strategy, the submissions, and the agency experience to help you navigate EMA, FDA, MHRA, and FAMHP, and reach patients with confidence.

What we offer

How we help your team

Practical, hands-on support, shaped around your products, your team, and the outcomes you need.

  • Regulatory strategy and roadmaps

    We map the fastest defensible route to approval for your product and target markets. You get a clear sequence of decisions, evidence needs, and milestones.

  • Marketing authorisation submissions

    We prepare and manage CTD and eCTD dossiers that stand up to review. Submissions are structured, consistent, and ready for the questions that follow.

  • Variations and lifecycle maintenance

    We keep your authorisations current as products, sites, and requirements change. Variations are planned and filed so supply is never at risk.

  • Market access and scientific advice

    We prepare and support scientific advice and market access across regions. Early alignment with regulators reduces surprises later.

  • Labelling and regulatory intelligence

    We keep labelling accurate and monitor the regulatory changes that affect your portfolio. You stay ahead of new requirements rather than reacting to them.

  • Agency interactions

    We prepare your team for meetings and correspondence with EMA, FDA, MHRA, and FAMHP. Clear, well-evidenced responses keep reviews moving.

Let's discuss your challenge

Tell us what you are working towards. We will bring the expertise, the plan, and the hands-on delivery to help your team get there.